This study sought to assess the prevalence of TT in RCC, its current management, and its association with venous thromboembolism (VTE), arterial thromboembolism (ATE), major bleeding (MB), and mortality.

JACC CardioOncology Editor-in-Chief and CME Editor
Bonnie Ky, MD, MSCE, FACC

Authors
Fleur H.J. Kaptein, MD
Frederikus A. Klok, MD, PhD

Important Dates

Date of Release: November 15, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: November 14, 2023